Oncolytics Provides Update on Pancreatic Cancer Program for Pelareorep

Updated plan follows PanCAN’s strategic re-evaluation of the Precision PromiseSM Program PanCAN US$5 million grant provides support for new GOBLET mFOLFIRINOX arm to proceed as planned New Phase 3 strategy provides significant value-creation opportunities SAN DIEGO, CA and CALGARY, AB,…